No evidence of SARS‐CoV‐2 transmission through transfusion of human blood products: A systematic reviewReview Published on 2021-07-192022-10-31 Journal: Ejhaem [Category] COVID-19, [키워드] acute respiratory syndrome Analysis article Blood blood product blood products Bone marrow CINAHL circulation coronavirus COVID‐19 COVID‐19 donors eight eligible Evidence Final Google Scholar Haematopoietic stem cells no evidence of Patient patients recipients Registered RT‐PCR SARS‐CoV‐2 SARS‐CoV‐2 Symptoms systematic review tested theoretical risk transfusion Transmission [DOI] 10.1002/jha2.263 PMC 바로가기 [Article Type] Review
Transfusion management of severe anaemia in African children: a consensus algorithm아프리카 아동의 중증 빈혈 수혈 관리: 합의 알고리즘Article Published on 2021-07-092024-08-26 Journal: British journal of haematology [Category] 말라리아, [키워드] African children Anaemia guidelines malaria transfusion [DOI] 10.1111/bjh.17429 PMC 바로가기 [Article Type] Article
Risque résiduel de la transmission par transfusion de l´infection du virus de l´hépatite B dû aux donneurs porteurs de l´infection du virus de l´hépatite B occulte à Yaoundé, CamerounResearch Published on 2021-07-062023-06-02 Journal: The Pan African Medical Journal [Category] B형 간염, [키워드] HBV Infection residual risk Risque résiduel transfusion Transmission VHB [DOI] 10.11604/pamj.2021.39.175.22365 PMC 바로가기 [Article Type] Research
SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic2020년 COVID-19 전염병 기간 동안 마다가스카르 헌혈자의 SARS-CoV-2 항체 혈청 유병률 추적 조사Multicenter Study Published on 2021-06-012022-09-12 Journal: EBioMedicine [Category] MERS, SARS, 진단, [키워드] anti-SARS-CoV-2 antibody Blood blood donor Blood donors collected Conducting contributed COVID-19 COVID-19 epidemic cumulative development Donor driving epidemic peak epidemic wave epidemiological Follow-up incidence Infection infection rates madagascar Prevent SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 seroprevalence Seroconversion Seroprevalence spring surveillance data the epidemic the United State transfusion [DOI] 10.1016/j.ebiom.2021.103419 PMC 바로가기 [Article Type] Multicenter Study
Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial입원 중인 COVID-19 환자의 회복기 혈장 사용의 안전성과 효능을 평가하기 위한 무작위 임상 시험(PERUCONPLASMA): 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2021-05-172022-09-01 Journal: Trials [Category] SARS, 임상, 진단, 치료기술, [키워드] 1:1 ABO blood type Acute coronary syndrome administration Adverse reaction Adverse reactions aliquot Aliquots All participants allocation anaphylaxis antibody Antigen assessment Bilirubin Blinding block blocks blood gas blood gas analysis blood type C-reactive protein calculated Capacity carried case report form clinical clinical trial clinical trials Coagulation Coma completion confidence level congestive heart failure contraindication control group convalescent plasma coronary syndrome COVID-19 COVID-19 disease COVID-19 pneumonia creatinine Critical Critical disease CRP current D-dimer decrease defined detect Diagnosis dialysis disease Disseminated intravascular coagulation dissemination Donor donors drop Duration Dynamics eCRF Efficacy electronic case report form element eligible enrolled enrolment etiology evaluate evaluated events Evolution exclusion criteria expected experimental group exploratory failure following gas analysis hemodynamic instability hemorrhage hospital hospital discharge Hospitalization Hospitalized hospitalized patient hospitalized patients Hypothesis Hypoxemia ICU IIb in-hospital mortality Inclusion Infarction Inflammatory information Informed consent intensive care intensive care unit Intervention intracranial hemorrhage intravascular coagulation Invasive mechanical ventilation investigator investigators jaundice Laboratory laboratory confirmation Laboratory test Lactate lactate dehydrogenase Length less Local lymphocyte male marker Mechanical mechanical ventilation mmHg molecular Mortality multi-organ failure Myocardial infarction Neutralizing antibodies number objective occur Older open open label outcome oxygen Oxygen requirement oxygen saturation PaO participant Patient performed plasma Platelets Pneumonia power power of 80% previous diagnosis Probability protocol Public Hospital public hospitals quantification randomization Randomized Randomized controlled trial rationale receive reduce reducing reduction Registered resolution of symptom respiratory respiratory rate routine clinical practice Safe Safety Sample size SARS-COV-2 infection score Secondary objectives serious adverse reaction Serious adverse reactions serologic serum serum creatinine severe COVID-19 Severe COVID-19 pneumonia severe disease SOFA specific type standard treatment standard treatment alone statistical analysis Study protocol Stupor subject supplementary material Total total bilirubin transfusion treatment arm Trial uncontrolled vasopressors Ventilation website with COVID-19 [DOI] 10.1186/s13063-021-05189-6 PMC 바로가기 [Article Type] Letter
Convalescent Plasma Transfusion for the Treatment of COVID-19 in Adults: A Global Perspective성인의 COVID-19 치료를 위한 회복기 혈장 수혈: 글로벌 관점Review Published on 2021-05-072022-09-10 Journal: Viruses [Category] SARS, 변종, [키워드] Administered aggregate clinical trials Consensus convalescent plasma convalescent plasma transfusion coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients COVID-19 symptoms donors Effectiveness Healthcare system Healthcare systems implementation include Infection Intervention limit mortality rate mortality rates Novel coronavirus novel coronavirus disease Odds ratio pandemic patient groups patients plasma random-effects model randomized clinical trial RCT RCTs recipient Recovered COVID-19 patients recruitment reducing reported Repurposed drug Repurposed drugs risk severity severity of COVID-19 Supply chain Support Symptoms therapeutic option Therapeutics transfusion treat Treatment Vaccine variant Ventilation was used world population [DOI] 10.3390/v13050849 PMC 바로가기 [Article Type] Review
High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples종적 회복기 혈장 샘플에서 SARS-CoV-2 스파이크를 표적으로 하는 항체의 고처리량 검출Clinical Trial Published on 2021-05-012022-09-11 Journal: Transfusion [Category] MERS, SARS, 임상, 진단, 치료기술, 치료제, [키워드] 293T acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antibodies antibody Antibody responses approach cell line convalescent convalescent plasma coronavirus coronavirus disease Coronavirus disease 2019 Coronaviruses correlated COVID-19 deaths Decline detect develop domain donors expressing flow cytometry full-length SARS-CoV-2 glycoprotein help High-throughput screening Humoral response humoral responses infecting Infection information longitudinal analysis Longitudinal studies longitudinal study observation pandemic performed persistence plasma post-symptom onset RBD RBD domain RBD-specific antibodies RBD-specific antibody Receptor-binding domain reduce respiratory responses Result SARS-CoV-2 SARS-CoV-2 spike severe acute respiratory syndrome Coronavirus severity of COVID-19 shown specific antibodies spike spike glycoproteins Spike-specific antibody the RBD the receptor-binding domain the SARS-CoV-2 transfusion Viral viral entry virus [DOI] 10.1111/trf.16318 PMC 바로가기 [Article Type] Clinical Trial
Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19메틸렌 블루 광화학 치료는 코로나19에 대한 혈액 안전 및 회복기 혈장 치료를 위한 신뢰할 수 있는 SARS-CoV-2 혈장 바이러스 비활성화 방법으로Research Article Published on 2021-04-162022-09-01 Journal: BMC Infectious Diseases [Category] MERS, SARS, 진단, 치료기술, [키워드] adjusted AIDS asymptomatic infection Blood blood product blood products Blood safety blood transfusions cells change clinical trial clinical trials Concentration Convalescent plasma therapy coronavirus COVID-19 COVID-19 cases Culture declined Effect Efficiency Final HIV treatment HIV-1 illumination Inactivated Vaccines inactivation infect Lipid Live virus Lower respiratory tract Lux median Methylene Methylene blue New coronavirus outbreak PCR photochemical Photochemical treatment plasma Plasma transfusion Plasma virus inactivation Quantitative recovering patients respiratory Result reverse transcription risk room temperature Safe SARS-CoV-2 SARS-CoV-2 virus SARS-CoV-2 virus strain Spread TCID50 temperature the SARS-CoV-2 therapy tissue tissue culture transfusion Treatment university upper or lower respiratory tract virus virus inactivation virus RNA virus titer viruses was used were measured Zhejiang [DOI] 10.1186/s12879-021-05993-0 PMC 바로가기 [Article Type] Research Article
Transfusion practices during the COVID-19 pandemic: An experience from a hematology daycare in IndiaArticle Published on 2021-04-012023-07-12 Journal: Transfusion and apheresis science : official journ [Category] SARS, [키워드] Blood Bank COVID-19 pandemic India lockdown transfusion [DOI] 10.1016/j.transci.2020.103025 PMC 바로가기
Blood Donations and Transfusions during the COVID-19 Pandemic in Spain: Impact According to Autonomous Communities and HospitalsArticle Published on 2021-03-272022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, SARS, [키워드] affected autonomous average Blood blood component caused Cohort Community COVID-19 COVID-19 pandemic decrease distribution donation eight Emergency Evolution hospital Impact increase in initial pandemic performed plasma Platelet Prospective Study RBC RBCs red blood cell reduction in Retrospective study significant decrease Spain state transfusion [DOI] 10.3390/ijerph18073480 PMC 바로가기 [Article Type] Article